title: Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.
abstract: Tissue factor (TF) pathway inhibitor (TFPI) is a well-characterized activated factor X (FXa)-dependent inhibitor of TF-initiated coagulation produced in two alternatively spliced isoforms, TFPIα and TFPIβ. The TFPIα C terminus has a basic sequence nearly identical to a portion of the factor V (FV) B domain necessary for maintaining FV in an inactive conformation via interaction with an acidic region of the B domain. We demonstrate rapid inhibition of prothrombinase by TFPIα mediated through a high-affinity exosite interaction between the basic region of TFPIα and the FV acidic region, which is retained in FXa-activated FVa and platelet FVa. This inhibitory activity is not mediated by TFPIβ and is lost upon removal of the acidic region of FVa by thrombin. The data identify a previously undescribed, isoform-specific anticoagulant function for TFPIα and are a unique description of physiologically relevant inhibition of prothrombinase. These findings, combined with previous descriptions of differential expression patterns of TFPIα and TFPIβ in platelets and endothelial cells, suggest that the TFPI isoforms may act through distinct mechanisms to inhibit the initial stages of intravascular coagulation, with TFPIβ acting to dampen TF expressed on the surface of vascular cells, whereas TFPIα dampens the initial prothrombinase formed on the activated platelet surface.
authors.affiliation: Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53226.
authors.forename: Jeremy P
authors.initials: JP
authors.lastname: Wood
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Bunce
authors.forename: Susan A
authors.initials: SA
authors.lastname: Maroney
authors.forename: Paula B
authors.initials: PB
authors.lastname: Tracy
authors.forename: Rodney M
authors.initials: RM
authors.lastname: Camire
authors.forename: Alan E
authors.initials: AE
authors.lastname: Mast
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D001777:Blood Coagulation / Q000502:physiology*; D015153:Blotting, Western; D019295:Computational Biology; D017124:Conserved Sequence / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D015951:Factor Xa / Q000378:metabolism; D005454:Fluorescence Polarization; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism* / Q000494:pharmacology; D008969:Molecular Sequence Data; D016415:Sequence Alignment; D013925:Thromboplastin / Q000037:antagonists & inhibitors*
chemical_list: D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor; D013925:Thromboplastin; D015951:Factor Xa
keywords: bleeding; hemophilia; thrombosis